- Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
- Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
- Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
- Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results
- Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia
More ▼
Key statistics
As of last trade, Design Therapeutics Inc (DSGN:NSQ) traded at 3.61, 85.82% above the 52 week low of 1.94 set on Aug 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.67 |
---|---|
High | 3.71 |
Low | 3.59 |
Bid | 3.60 |
Offer | 3.61 |
Previous close | 3.72 |
Average volume | 242.80k |
---|---|
Shares outstanding | 56.49m |
Free float | 35.78m |
P/E (TTM) | -- |
Market cap | 210.16m USD |
EPS (TTM) | -1.19 USD |
Data delayed at least 15 minutes, as of Apr 30 2024 19:23 BST.
More ▼